Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 11Terminated 6Active not recruiting 4Unknown 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 12Rectal Neoplasms 7Colonic Neoplasms 5Pancreatic Neoplasms 3Stomach Neoplasms 2Glioblastoma 2Breast Neoplasms 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Solid Tumor Malignancy 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Prostatic Neoplasms 1Pediatric Solid Tumors 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasm Metastasis 1Lung Neoplasms 1Gliosarcoma 1Gallbladder Neoplasms 1Colorectal Adenocarcinoma Metastatic to the Liver 1Central Nervous System Neoplasms 1Breast Neoplasms, Male 1Brain Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1Astrocytoma 1

Interventions

Radiotherapy 5Gemcitabine 4Cyclophosphamide 4pazopanib 3Docetaxel 3Biopsy 3pembrolizumab 2olaparib 2liposomal doxorubicin 2Vincristine 2Trastuzumab 2Trabectedin 2Temozolomide 2Taxes 2Surgical Procedures, Operative 2Specimen Handling 2Proton Therapy 2Nivolumab 2Magnetic Resonance Spectroscopy 2Ifosfamide 2Filgrastim 2Etoposide 2Drug Therapy 2Doxorubicin 2Celecoxib 2Carboplatin 2Ascorbic Acid 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2trastuzumab biosimilar HLX02 1tozuleristide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Sarcoma × Irinotecan × Clear all
NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡